| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $59.9M | — | +44.7% |
| Cost of Revenue | $17.5M | — | +29.3% |
| Gross Profit | $42.3M | — | +52.2% |
| R&D Expense | $5.2M | — | +3.7% |
| SG&A Expense | $43.6M | — | +9.8% |
| Operating Income | -$6.5M | — | +61.6% |
| Pre-tax Income | -$13.1M | — | +33.9% |
| Income Tax | $288K | — | -68.5% |
| Net Income | -$13.4M | — | +35.4% |
| EPS (Basic) | -$0.45 | — | +35.7% |
| EPS (Diluted) | -$0.45 | — | +35.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $68.1M | -9.9% | -1.6% |
| Accounts Receivable | $77.1M | -0.5% | +21.9% |
| Inventory | $86.7M | +1.2% | -4.2% |
| Current Assets | $245.8M | -1.6% | +6.1% |
| Total Assets | $351.0M | -1.7% | +5.3% |
| Current Liabilities | $83.2M | +1.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | +79.2% |
| Capital Expenditures | $1.9M | — | +146.1% |
| Investing Cash Flow | -$2.0M | — | -46.7% |
| Financing Cash Flow | -$864K | — | -325.6% |
| Free Cash Flow | -$6.2M | — | +71.3% |
| +20.4% |
| Long-term Debt | $248.6M | +0.4% | +12.8% |
| Total Liabilities | $336.3M | +0.8% | +14.1% |
| Stockholders' Equity | $14.8M | -37.2% | -61.7% |